The world’s first tooth-regrowth drug is on the brink of reality! Japanese pharmaceutical startup Toregem Biopharma is set to initiate clinical trials in July next year. This groundbreaking drug, developed after successful tests on mice and ferrets, aims to stimulate tooth growth by suppressing a specific gene. If human trials yield positive results, a clinical trial for children with anodontia is planned for 2025. The goal? To offer an additional option alongside dentures and implants for those without a full set of teeth. Dr. Katsu Takahashi’s dream of growing new teeth is becoming a promising reality.
Positive News Foundation is a certified non-profit sharing only the best positive world news.
All copyrights belong to the source.
No copyright infringement is intended.
Email email@example.com to fix/remove.
GET POSITIVE NEWS PER E-MAIL
ONLY BEST POSITIVE NEWS
FROM LAST WEEK
FOR FREE IN YOUR E-MAIL INBOX
ONLY 1X PER WEEK